Collectively, these observations may hold some prognostic value for evaluation of CRC over healthy controls using Bio-Plex analysis of plasma G-CSF, IFN-G, IL-4, IL-6, IL-8, IL-9, MCP-1, MIP-1B and PDGF-BB in a clinical setting. This evidence concerns the gene IL9 and colorectal carcinoma.